Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), bought 72,000 shares at $2.75 ($198K) on 2019-10-25, disclosed to the SEC on 2019-10-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |
| TXMD | BUY | 2019-08-12 | $310K | — | Filing → |